NICE (UK National Institute for Clinical Excellence) for Europe? Not yet awhile
This article was originally published in Clinica
The merits of the unique National Institute for Clinical Excellence were sung loud at the Clinical Excellence 2001 annual meeting last week (see reports on page 8). But one of the drawbacks of the UK's national model of best practice guidance is that it doesn't travel well. At least not for the present. For while the European Commission prepares next year to embrace closer integration of the work of Europe's health technology assessment bodies (subject to the adoption of EU public health strategy), the establishment of a single health technology assessment body for Europe may remain something for the more distant future.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.